Anaergia Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Assaf Onn

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.3yrs
Gemiddelde ambtstermijn bestuur	1.6yrs

Recente managementupdates

Recent updates

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

May 16

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

May 14

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Nov 13

CEO

Assaf Onn

less than a year

Tenure

Mr. Assaf Onn is Director of Anaergia Inc. from April 01, 2024 and serves as its Interim Chief Executive Officer. Mr. Onn is currently the Chief Operating Officer of Marny. Mr. Onn holds the position of Ch...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yaniv Scherson	Chief Operating Officer	3.7yrs	CA$638.46k	0.22% CA$ 376.0k
Andrew Benedek	Executive Director	less than a year	CA$461.34k	18.14% CA$ 30.8m
Hani El-Kaissi	Chief Development Officer	2.1yrs	CA$624.56k	0.22% CA$ 376.0k
Kunal Shah	Chief Growth Officer	no data	CA$630.87k	0.0042% CA$ 7.1k
Assaf Onn	Interim CEO & Director	no data	geen gegevens	geen gegevens
Gregory Wolf	Interim Chief Financial Officer	less than a year	geen gegevens	0.074% CA$ 125.0k
Sasha Rollings-Scattergood	Vice President of Technology	5.8yrs	geen gegevens	0% CA$ 0
Scott Hodgdon	General Counsel	less than a year	geen gegevens	geen gegevens
Juan Josse	Chief Engineer	12.8yrs	CA$429.65k	geen gegevens
Alessandro Massone	Commercial Managing Director of Europe	2.5yrs	geen gegevens	geen gegevens

2.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van ANRG wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Andrew Benedek	Executive Director	17.8yrs	CA$461.34k	18.14% CA$ 30.8m
Assaf Onn	Interim CEO & Director	less than a year	geen gegevens	geen gegevens
Eugene Siklos	Independent Observer	no data	geen gegevens	geen gegevens
Stan Simmons	Independent Director	1.6yrs	CA$75.00k	0.055% CA$ 94.0k
Diana Mourato Benedek	Director	17.8yrs	geen gegevens	geen gegevens
Peter Gross	Lead Independent Director	5.8yrs	CA$110.00k	0.028% CA$ 47.1k
Ronen Kantor	Independent Director	less than a year	geen gegevens	3.76% CA$ 6.4m
Ohad Epschtein	Chairman	less than a year	geen gegevens	geen gegevens

1.6yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van ANRG wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.6 jaar), wat duidt op een nieuw bestuur.

Anaergia Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Interim Chief Financial Officer recently bought CA$78k worth of stock

Independent Director recently bought CA$61k worth of stock

Executive Director recently bought CA$109k worth of stock

Anaergia Inc. Announces Appointment of Gregory Wolf, Interim Chief Financial Officer to Permanent Chief Financial Officer

Less than half of directors are independent

Anaergia Inc. Announces Chairman Changes

Recent updates

Third quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.48 loss in 3Q 2023)

Anaergia Inc.'s (TSE:ANRG) 31% Jump Shows Its Popularity With Investors

Interim Chief Financial Officer recently bought CA$78k worth of stock

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Independent Director recently bought CA$61k worth of stock

Executive Director recently bought CA$109k worth of stock

Anaergia Inc. Announces Appointment of Gregory Wolf, Interim Chief Financial Officer to Permanent Chief Financial Officer

Second quarter 2024 earnings released: CA$0.04 loss per share (vs CA$1.78 loss in 2Q 2023)

Anaergia Inc. (TSE:ANRG) Soars 92% But It's A Story Of Risk Vs Reward

Less than half of directors are independent

Anaergia Inc. Announces Chairman Changes

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.17 loss in 1Q 2023)

Less than half of directors are independent

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Resignation of Frank Mckenna as Board of Directors

Anaergia Inc., Annual General Meeting, Jun 24, 2024

Less than half of directors are independent

Anaergia Inc. Announces Board Changes

Price target decreased by 20% to CA$0.33

New major risk - Shareholder dilution

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

New minor risk - Profitability

Forecast breakeven date pushed back to 2025

Insufficient new directors

Anaergia Inc. to Report Q3, 2023 Results on Nov 14, 2023

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

Anaergia Inc. Withdraws Earnings Guidance for the Fiscal Year 2023

Forecast breakeven date pushed back to 2025

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Anaergia Inc. to Report Q2, 2023 Results on Aug 14, 2023

Price target increased by 9.1% to CA$2.29

Price target decreased by 25% to CA$2.10

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Appointment of Andrew Spence as Chief Financial Officer

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

Price target increased by 16% to CA$5.48

Anaergia Inc. Updates Earnings Guidance for the Fiscal Year of 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.3% to CA$4.73

Consensus EPS estimates have been downgraded.

Consensus EPS estimates have been downgraded.

Price target decreased by 11% to CA$7.56

Insufficient new directors

Price target decreased by 7.1% to CA$8.53

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CA$17.29

Anaergia Inc. Revises Revenue Guidance for Fiscal 2022

Anaergia Inc. to Report Q3, 2022 Results on Nov 10, 2022

Anaergia Inc. Appoints Paula Myson as Chief Financial Officer

Anaergia Inc. Reaffirms Financial Guidance for the Fiscal 2022 and Fiscal 2023

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. Announces Executive Changes

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Anaergia Inc. to Report Q1, 2022 Results on May 12, 2022

Anaergia Inc. has completed a Follow-on Equity Offering in the amount of CAD 60 million.

Anaergia Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings: Revenues exceed analyst expectations

Anaergia Inc. Provides Earnings Guidance for the Fiscal Year 2022 and 2023

Anaergia Inc. to Report Q4, 2021 Results on Mar 28, 2022